| Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia F Salton, P Confalonieri, GU Meduri, P Santus, S Harari, R Scala, S Lanini, ... Open forum infectious diseases 7 (10), ofaa421, 2020 | 169 | 2020 |
| Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial F Perrone, MC Piccirillo, PA Ascierto, C Salvarani, R Parrella, AM Marata, ... Journal of translational medicine 18 (1), 405, 2020 | 154 | 2020 |
| Early treatment with noninvasive positive pressure ventilation prolongs survival in amyotrophic lateral sclerosis patients with nocturnal respiratory insufficiency P Carratù, L Spicuzza, A Cassano, M Maniscalco, F Gadaleta, ... Orphanet journal of rare diseases 4, 1-7, 2009 | 117 | 2009 |
| Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? LEGW Vanfleteren, JWH Kocks, IS Stone, R Breyer-Kohansal, T Greulich, ... Thorax 69 (1), 72-79, 2014 | 101 | 2014 |
| Gender difference in sleep profile of severely obese patients with obstructive sleep apnea (OSA) O Resta, GE Carpagnano, D Lacedonia, G Di Gioia, T Giliberti, A Stefano, ... Respiratory medicine 99 (1), 91-96, 2005 | 96 | 2005 |
| Characterization of obstructive sleep apnea–hypopnea syndrome (OSA) population by means of cluster analysis D Lacedonia, GE Carpagnano, R Sabato, MM Storto, GA Palmiotti, ... Journal of sleep research 25 (6), 724-730, 2016 | 89 | 2016 |
| Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma–COPD overlap syndrome phenotype D Lacedonia, GP Palladino, MP Foschino-Barbaro, G Scioscia, ... International journal of chronic obstructive pulmonary disease, 1811-1817, 2017 | 85 | 2017 |
| Application of machine learning to predict obstructive sleep apnea syndrome severity C Mencar, C Gallo, M Mantero, P Tarsia, GE Carpagnano, ... Health informatics journal 26 (1), 298-317, 2020 | 74 | 2020 |
| Prevalence of comorbidities in patients with obstructive sleep apnea syndrome, overlap syndrome and obesity hypoventilation syndrome D Lacedonia, GE Carpagnano, G Patricelli, M Carone, C Gallo, I Caccavo, ... The clinical respiratory journal 12 (5), 1905-1911, 2018 | 73 | 2018 |
| Daytime PaO2 in OSAS, COPD and the combination of the two (overlap syndrome) D Lacedonia, GE Carpagnano, M Aliani, R Sabato, MPF Barbaro, ... Respiratory medicine 107 (2), 310-316, 2013 | 73 | 2013 |
| Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8 GE Carpagnano, GP Palladino, D Lacedonia, A Koutelou, S Orlando, ... BMC cancer 11, 1-9, 2011 | 73 | 2011 |
| Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab GE Carpagnano, G Scioscia, D Lacedonia, G Curradi, ... Journal of asthma and allergy, 83-90, 2019 | 66 | 2019 |
| Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma MPF Barbaro, A Spanevello, GP Palladino, FG Salerno, D Lacedonia, ... European journal of internal medicine 25 (1), 92-96, 2014 | 66 | 2014 |
| Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS) O Resta, P Carratu, GE Carpagnano, M Maniscalco, G Di Gioia, ... Journal of endocrinological investigation 28, 893-899, 2005 | 61 | 2005 |
| A real-life multicenter national study on nintedanib in severe idiopathic pulmonary fibrosis S Harari, A Caminati, V Poletti, M Confalonieri, S Gasparini, D Lacedonia, ... Respiration 95 (6), 433-440, 2018 | 58 | 2018 |
| Microparticles in sputum of COPD patients: a potential biomarker of the disease? D Lacedonia, GE Carpagnano, T Trotta, GP Palladino, MA Panaro, ... International journal of chronic obstructive pulmonary disease, 527-533, 2016 | 57 | 2016 |
| Mitochondrial DNA alteration in obstructive sleep apnea D Lacedonia, GE Carpagnano, E Crisetti, G Cotugno, GP Palladino, ... Respiratory research 16, 1-7, 2015 | 53 | 2015 |
| Non-invasive study of airways inflammation in sleep apnea patients GE Carpagnano, D Lacedonia, MP Foschino-Barbaro Sleep medicine reviews 15 (5), 317-326, 2011 | 50 | 2011 |
| Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients D Lacedonia, G Scioscia, C Santomasi, P Fuso, GE Carpagnano, ... Scientific Reports 11 (1), 19251, 2021 | 47 | 2021 |
| Adherence to GOLD guidelines in real-life COPD management in the Puglia region of Italy GA Palmiotti, D Lacedonia, V Liotino, P Schino, F Satriano, PL Di Napoli, ... International journal of chronic obstructive pulmonary disease, 2455-2462, 2018 | 47 | 2018 |
onofrio restaProfessore Ordinario Malattie dell'Apparato Respiratorio. Università degli Studi di Bariuniba.it의 이메일 확인됨
